期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

sRAGE与糖尿病及其并发症 被引量：2

sRAGE, diabetes and its complications
原文传递
导出
摘要 晚期糖基化终末产物（AGEs）与其受体（RAGE）在糖尿病及其并发症的发生、发展中起重要作用。缺少胞内区的RAGE称为可溶性RAGE（sRAGE）。其可阻断配体与RAGE的结合。糖尿病患者sRAGE水平明显降低，而他汀类、噻唑烷二酮类、血管紧张素转换酶抑制剂等药物可以提高血清sRAGE水平。对sRAGE的进一步研究有可能为糖尿病及其并发症的治疗提供新的药物。 Interaction of advanced glycation end products （AGEs） with their receptor （RAGE） plays an important role in the oeeuranee and development of diabetes and its complications. RAGE has an endogenous secretory receptor form, termed soluble RAGE （sRAGE）, which might act as an endogenous competitive inhibitor of RAGE. The level of sRAGE decreases in patients with diabetes, while some drugs, such as statins, thiazolidinediones, inhibitors of angiotensin-converting enzyme also increase plasma sRAGE level. Further studies of sRAGE may provide a new drug for the treatment of diabetes and its complications.
作者 苏旭东 田亚强 张光珍
机构地区 山东省聊城市人民医院内分泌科
出处 《国际内分泌代谢杂志》 2011年第4期249-251,共3页 International Journal of Endocrinology and Metabolism
关键词 糖尿病 可溶性晚期糖基化终末产物受体 糖尿病并发症 Diabetes mellitus Soluble receptor of advanced glyeation end products Diabetic com- plication
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献23

  • 1Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products : sparking the development of diabetic vascular injury. Circulation ,2006,114:597-605.
  • 2Raucci A,Cugusi S, Autonelli A, et al. A soluble form of the re- ceptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the shed-dase A Disintegrin And Metalloprotease 10 (ADAM10). FASEB J, 2008,22 : 3716 -3727.
  • 3Hudson BI, Carter AM, Harja E, et al. Identification, classifica- tion, and expression of RAGE gene splice variants. FASEB J, 2005,22 : 1572-1580.
  • 4Norata GD, Garlaschelli K, Grigore L, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the genera/ popula- tion. Nutr Metab Cardiovasc Dis,2009,19 : 129-134.
  • 5Santilli F, Bucciarelli L, Noto D, et al. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radic Biol Med,2007,43 : 1255-1262.
  • 6Tam XH, Shiu SW, Leng L, et al. Enhanced expression of receptor for advanced glycation end-products is associated with low circu-lating soluble isoforms of the receptor in type 2 diabetes. Clin Sci (Lond) ,2011,120:81-89.
  • 7Basta G,Sironi AM, Lazzerini G, et al. Circulating soluble recep- tor for advanced glycation end products is inversely associatedwith glycemic control and S100A12 protein. J Clin Endoerinol Metab ,2006,91:4628-4634.
  • 8Devangelio E, Santilli F, Formoso G, et al. Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med ,2007,43:511-518.
  • 9Kim W, Hudson BI, Moser B, et al. Receptor for advanced glyca- tion end products and its ligands:a journey from the complica-tions of diabetes to its pathogenesis. Ann N Y Acad Sci, 2005, 1403:553-561.
  • 10Hudson BI, Moon YP, Kalea AZ,et al. Association of serum solu- ble receptor for advanced glyeation end-products with subclinicalcerebrovascular disease: The Northern Manhattan Study (NO- MAS). Atherosclerosis. 2011,216 : 192-198.

二级参考文献4

  • 1刘华,李学旺,李航.晚期糖基化终末产物及其受体与糖尿病肾病[J].国外医学（泌尿系统分册）,2005,25(5):658-661. 被引量：4
  • 2Raptis AE,Viberti G.Pathogenesis of diabetic nephropathy[J].Exp Clin Endocr Diab,2001,109(2):424-437.
  • 3Angeliga B,Per M,Humper T,et al.Understanding RAGE,the receptor for advanced glycation end products[J].J Mol Med,2005,83(11):876-886.
  • 4Capon DJ,Chamow SM,Mordenti J,et al.Designing CD4 immunoadhesins for AIDS therapy[J].Nature,1989,337(6207):525-531.

共引文献2

同被引文献19

  • 1YAMAGISHI S, MATSUI T. Soluble form of a receptor for ad- vanced glycation end products(sRAGE) as a biomarker[J]. Fron- tiers Bioscience, 2010, 1(2): 1184-1195.
  • 2NIN JW, JORSAL A, FERREIRA I, et al. Higher plasma solu-ble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes:a 12-year follow-up study[J]. Dia- betes, 2010, 59: 2027-2032.
  • 3ZYGUN DA, STEINER LA, JOHNSTON AJ, et al. Hyper- glycemia and brain tissue Ph after traumatic brain injury[J]. Neurosurgery, 2004, 55(4): 877-881.
  • 4ROVLIAS A, KOTSOU S. The influence of hyperglycemia on neurological outcome in patients with severe brain injury [J]. Neurosurgery, 2000, 46(5): 335-343.
  • 5CALFEE CS, WARE LB, EISNER MD, et al. Plasma receptor for advanced glycation end products and clinical outcomes in a- cute lung injury[J]. Thorax, 2008, 63: 1083-1089.
  • 6NARVAEZ-RIVERA RM, RENDON A, SALINAS- CARMONA MC, et al. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis[J]. BMC Infect Dis, 2012, doi: 10.1186/1471-2334-12-15.
  • 7BOPP C, HOFER S, WEITZ J. sRAGE is elevated in septic patients and associated with patients outcome[J]. The Journal of Surgical Research, 2008, 147(1): 79-83.
  • 8ARABI YM, DEHBI M, RISHU AH, et al. sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive in- sulin therapy[J]. Critical Care, 2011, 15(4): R203.
  • 9柏凤,俞伟男.血糖波动与糖尿病慢性并发症[J].徐州医学院学报,2009,29(2):137-140. 被引量：6
  • 10章晓燕,钟远,胡廷军.减少血糖波动对老年糖尿病患者血管内皮功能的影响[J].实用老年医学,2009,23(1):45-48. 被引量：7

引证文献2

二级引证文献6

国际内分泌代谢杂志
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部